ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
0.00%
US Dollar vs AUD
1.53421
0.00%
Bitcoin
97,028.30
0.61%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Onconova Therapeutics Inc (ONTX)

  7. Onconova Therapeutics Inc (ONTX) News

ONTX

Onconova Therapeutics (ONTX)

Onconova Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ONTX
DateTimeSourceHeadlineSymbolCompany
10/02/202409:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
10/02/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
09/02/202408:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
28/10/202307:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
28/10/202307:35Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
30/09/202307:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
16/08/202306:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
15/08/202307:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ONTXOnconova Therapeutics Inc
11/08/202307:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
05/08/202306:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
05/08/202306:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ONTXOnconova Therapeutics Inc
22/07/202306:50Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ONTXOnconova Therapeutics Inc
22/07/202306:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ONTXOnconova Therapeutics Inc
12/07/202314:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ONTXOnconova Therapeutics Inc
01/07/202306:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ONTXOnconova Therapeutics Inc
14/06/202306:55Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
08/06/202306:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ONTXOnconova Therapeutics Inc
16/05/202307:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
09/05/202322:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ONTXOnconova Therapeutics Inc
31/03/202307:47Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ONTXOnconova Therapeutics Inc
15/03/202310:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
15/03/202309:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
15/03/202309:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ONTXOnconova Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ONTX

Your Recent History

BIT
UC915F
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36